News
Phase 1 data shows encouraging safety and niche efficacy. Click here to find out why I maintain a buy rating for SDGR stock.
The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Digital ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
The adoption of AI agents in healthcare is an essential strategy for institutions that seek efficiency, agility and smarter ...
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
The Joint Commission June 11 announced a new partnership with the Coalition for Health AI to help accelerate the development ...
Rhythm Technologies, Inc.'s Q1 2025 growth, AI innovations, and market expansion. Click for why I upgraded IRTC to Buy ...
Some FDA staff said Elsa often gave wrong answers, what experts call “hallucinations”, and has to be double-checked.
The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...
2d
RetailWire on MSNMcDonald’s Stock Downgraded for the 3rd Time in a Week; Analysts Blame Rising GLP-1 Drug PopularityMcDonald’s shares have now been cut by analysts three times in as many trading days, with the latest “buy-to-sell” slap from ...
As pharmaceutical and medical device companies race to modernize how they engage doctors and patients, leaders face a central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results